Radial vs Femoral Access in ACS Patients Undergoing Complex PCI Is Associated With Consistent Bleeding Benefit and No Excess of Risks

Autor: Antonio Landi, Mattia Branca, Pascal Vranckx, Sergio Leonardi, Enrico Frigoli, Dik Heg, Paolo Calabro, Giovanni Esposito, Gennaro Sardella, Carlo Tumscitz, Stefano Garducci, Giuseppe Andò, Ugo Limbruno, Paolo Sganzerla, Andrea Santarelli, Carlo Briguori, Jose M. de la Torre Hernandez, Giovanni Pedrazzini, Stephan Windecker, Marco Valgimigli
Rok vydání: 2022
Předmět:
Zdroj: Canadian Journal of Cardiology. 38:1488-1500
ISSN: 0828-282X
Popis: The comparative effectiveness of transradial (TRA) compared with transfemoral (TFA) access in acute coronary syndrome (ACS) patients undergoing complex percutaneous coronary intervention (PCI) remains unclear.Among 8404 ACS patients in the Minimising Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX (MATRIX)-Access trial, 5233 underwent noncomplex (TRA: n = 2590; TFA: n = 2643) and 1491 complex (TRA: n = 777; TFA: n = 714) PCI. Co-primary outcomes were major adverse cardiovascular events (MACE, the composite of all-cause mortality, myocardial infarction, or stroke) and the composite of MACE and Bleeding Academic Research Consortium (BARC) type 3 or 5 bleeding (net adverse cardiovascular events [NACE]) at 30 days.Rates of 30-day MACE (HR 0.94, 95% CI 0.72-1.22) or NACE (HR 0.89, 95% CI 0.69-1.14) did not significantly differ between groups in the complex PCI group, whereas both primary end points were lower (HR 0.84, 95% CI 0.70-1.00; HR 0.83, 95% CI 0.70-0.98; respectively) with TRA among noncomplex PCI patients, with negative interaction testing (PAmong ACS patients, PCI complexity did not affect the comparative efficacy and safety of TRA vs TFA, whereas the absolute risk reduction of access-site major bleeding was greater with TRA compared with TFA in complex as opposed to noncomplex PCI.
Databáze: OpenAIRE